Loading…
Myomo, Inc. is projected to rise to $1.25 by 2027, a +21% move from its current price of $1.04. MYO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9839 | $1.04 | $1.10 | 0.00% |
| Aug 6 | $0.9616 | $1.04 | $1.12 | 0.00% |
| Aug 7 | $0.9448 | $1.04 | $1.14 | +0.01% |
| Aug 8 | $0.9309 | $1.04 | $1.16 | +0.01% |
| Aug 9 | $0.9188 | $1.04 | $1.18 | +0.01% |
| Aug 10 | $0.908 | $1.04 | $1.19 | +0.01% |
| Aug 11 | $0.8982 | $1.04 | $1.20 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8982 | $1.04 | $1.20 | +0.01% |
| Week 2 | $0.8454 | $1.04 | $1.28 | +0.03% |
| Week 3 | $0.8069 | $1.04 | $1.34 | +0.04% |
| Week 4 | $0.7759 | $1.04 | $1.40 | +0.05% |
| Week 5 | $0.7496 | $1.04 | $1.44 | +0.07% |
| Week 6 | $0.7266 | $1.04 | $1.49 | +0.08% |
| Week 7 | $0.7061 | $1.04 | $1.53 | +0.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Myomo, Inc. is a wearable medical robotics company that designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach.
Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc.
was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
MYO is currently priced at $0.955 and has a market cap of $40.96M, ranking 5405. The stock shows a path of forecasted upside over the coming years with varying sentiment by year.
The 2026 forecast average is $0.955 with a 0% return, followed by 2027 average of $1.17 and a 22.5% ROI in a bullish year. The 2028 and 2029 forecasts show average prices of $1.14 and $1.12 with respective ROIs of 19.7% and 17.6%, continuing a neutral to slightly positive outlook.
Longer-range forecasts project continued upside: 2032 average $1.69 (76.9% ROI, bullish), 2033 average $2.02 (111.4%), 2034 average $2.20 (129.9%), 2035 average $2.25 (135.7%), 2040 average $3.99 (318.2%), and 2050 average $5.04 (427.6%), with bullish sentiment prevailing in later years.
A major floor 38.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.5% below — buyers have tended to step in here.
The nearest ceiling, 23.1% above — a clean break opens room to run.
A major ceiling 48.1% above — clearing it would confirm fresh momentum.
Key MYO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MYO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.991 | Buy | $0.991 | Buy |
| MA 10 | $0.98 | Buy | $0.9984 | Buy |
| MA 20 | $1.04 | Buy | $1.03 | Buy |
| MA 50 | $1.12 | Sell | $1.04 | Sell |
| MA 100 | $0.9452 | Buy | $1.02 | Buy |
| MA 200 | $0.9267 | Buy | $1.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.69 | Neutral |
| Stoch RSI (14) | 85.54 | Sell |
| CCI (20) | -28.17 | Neutral |
| Williams %R (14) | -47.62 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -9.01 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 52.38 | Neutral |
| TRIX (15) | -0.54 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 44.68 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 0.97 | Buy |
| ADX (14) | 11.10 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL with RSI at 50. The 50-day simple moving average is $1.11 and the 200-day simple moving average is $0.9303. Support is identified at $0.90 and resistance at $1.53.
The 30-day price range runs from $0.6608 to $1.38, reflecting a relatively wide swing as the stock trades near the current level. Annualized volatility is estimated at 100%, underscoring notable price fluctuation.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.64 | $1.04 | $1.32 | 0% | Neutral | |
| $0.9145 | $1.25 | $1.86 | +21% | Bullish | |
| $0.8667 | $1.27 | $2.00 | +22% | Bullish | |
| $0.8109 | $1.25 | $2.07 | +20% | Neutral | |
| $0.7544 | $1.22 | $2.11 | +17% | Neutral | |
| $0.8095 | $1.36 | $2.45 | +31% | Bullish | |
| $1.07 | $1.88 | $3.48 | +81% | Bullish | |
| $1.21 | $2.22 | $4.23 | +114% | Bullish | |
| $1.30 | $2.47 | $4.81 | +138% | Bullish | |
| $1.26 | $2.50 | $4.99 | +140% | Bullish | |
| $2.04 | $4.53 | $9.94 | +336% | Bullish | |
| $2.57 | $5.71 | $13.14 | +449% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.64 | $1.04 | $1.25 | +0.00% |
| September 2026 | $0.8189 | $0.9954 | $1.26 | -4.29% |
| October 2026 | $0.8452 | $1.04 | $1.35 | +4.66% |
| November 2026 | $0.8292 | $1.03 | $1.36 | -0.77% |
| December 2026 | $0.7825 | $0.9858 | $1.32 | -4.64% |
Click any year to see its month-by-month MYO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MYO is projected to trade between $0.64 and $1.32, averaging $1.04 — a potential gain of 0% from today's $1.04. Price action looks broadly range-bound.
Myomo, Inc.'s 2027 outlook centres on $1.25, within a $0.9145 to $1.86 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, MYO could reach as high as $2.00, with a base case around $1.27 and support toward $0.8667 — roughly +22% from $1.04. Momentum favours further upside here.
Expect MYO to range from $0.8109 to $2.07 through 2029. The $1.25 average target implies a +20% move from current prices. That is -1% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The MYO price prediction for 2030 points to an average of $1.22 (low $0.7544, high $2.11) — a potential gain of +17% on today's $1.04. Price action looks broadly range-bound.
In 2031, MYO is projected to trade between $0.8095 and $2.45, averaging $1.36 — a potential gain of +31% from today's $1.04. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Myomo, Inc.'s 2032 outlook centres on $1.88, within a $1.07 to $3.48 range. That is up +38% on the projected 2031 average. That marks a +81% change versus current levels. Momentum favours further upside here.
By 2033, MYO could reach as high as $4.23, with a base case around $2.22 and support toward $1.21 — roughly +114% from $1.04. Buyers look set to stay in control over this stretch.
Expect MYO to range from $1.30 to $4.81 through 2034. The $2.47 average target implies a +138% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The MYO price prediction for 2035 points to an average of $2.50 (low $1.26, high $4.99) — a potential gain of +140% on today's $1.04. Buyers look set to stay in control over this stretch.
In 2040, MYO is projected to trade between $2.04 and $9.94, averaging $4.53 — a potential gain of +336% from today's $1.04. That is up +81% on the projected 2035 average. Momentum favours further upside here.
Myomo, Inc.'s 2050 outlook centres on $5.71, within a $2.57 to $13.14 range. That is up +26% on the projected 2040 average. That marks a +449% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MYO today (≈ 961.538462 MYO) could be worth
$5,492.5
+$4,492.5 (+449%) by 2050 · US Dollar
Based on the average projected MYO price of $5.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MYOwould be worth at today's price.
$1,000 invested in MYO on Jul 31, 2025 (≈ 518.134729 MYO) would be worth
$538.86
-$461.14 (-46.1%) today · 0.54× · US Dollar
Based on a MYO entry price of $1.93 vs. today's $1.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.97 | $1,072.16 | +7.2% |
| 1 month ago | $1.04 | $1,000 | +0.0% |
| 3 months ago | $0.9 | $1,155.56 | +15.6% |
| 6 months ago | $0.876 | $1,187.21 | +18.7% |
| 1 year ago | $1.93 | $538.86 | -46.1% |
| All time (5.0y) ago | $7.92 | $131.31 | -86.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MYO forecast.
Our base-case forecast reaches $2.10 around 2033.
Implied market cap at $2.10: $81.14M
The multi-year forecast shows meaningful upside over the longer horizon. Notable milestones include 2027 with an average price of $1.17 and a 22.5% ROI in a bullish year, and 2032 with an average of $1.69 and a 76.9% ROI in a bullish year. 2033 is projected to average $2.02 with a 111.4% ROI, continuing the bullish tilt into the mid-2030s (2034 avg $2.20, 129.9% ROI; 2035 avg $2.25, 135.7% ROI).
By 2040 the forecast calls for an average of $3.99 and a 318.2% ROI, with bullish sentiment continuing. By 2050 the average is $5.04 and the ROI is 427.6%, again with bullish sentiment. The 2030 forecast shows a min of $0.697, an average of $1.12, a max of $1.95, and a 17.8% ROI, with neutral sentiment.
These figures illustrate a long-run path to higher valuations, while recognizing that these are estimates, not guarantees, and subject to market uncertainty.
Tap a question to reveal the answer.
2030 forecast: min $0.697, avg $1.12, max $1.95; ROI 17.8%; sentiment NEUTRAL.
Forecasts show upside over time, with 2027 avg $1.17 (ROI 22.5%, BULLISH) and 2040 avg $3.99 (ROI 318.2%, BULLISH), culminating in 2050 avg $5.04 (ROI 427.6%, BULLISH). However, 2026 shows 0% ROI and NEUTRAL sentiment; forecasts are estimates, not guarantees.
Yes. The 2033 forecast has an average of $2.02 and a max of $3.84, and the 2034 max is $4.28, indicating the possibility of reaching and exceeding $2 according to the forecast.
Current price is $0.955 and market cap is $40.96M.
2030 forecast: min $0.697, avg $1.12, max $1.95; ROI 17.8%; sentiment NEUTRAL.
Myomo, Inc. Community Discussion
0Share your Myomo, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.